LiveOne (LVO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here is how LiveOne (LVO) and Perdoceo Education (PRDO) have performed compared to their sector so far this year.
LVO, MU and CLX highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.
The consensus price target hints at a 122.9% upside potential for LiveOne (LVO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, LiveOne (LVO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
The mean of analysts' price targets for LiveOne (LVO) points to a 121.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LiveOne (LVO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
LiveOne, Inc. (LVO) Q3 2026 Earnings Call Transcript
LiveOne (LVO) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.3 per share a year ago.
Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.
LiveOne, Inc. ( LVO ) Q2 2026 Earnings Call November 12, 2025 10:00 AM EST Company Participants Ryan Carhart - CFO, Treasurer, Secretary, Controller & VP Robert Ellin - Founder, Chairman & CEO Conference Call Participants Brian Kinstlinger - Alliance Global Partners, Research Division Sean McGowan - ROTH Capital Partners, LLC, Research Division Presentation Operator Thank you for standing by. Welcome to LiveOne Q2 Fiscal 2026 Financial Results and Business Update Conference Call.
LiveOne (LVO) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.2 per share a year ago.